Literature DB >> 1371542

Protection of mice from lethal influenza by defective interfering virus: T cell responses.

L McLain1, D J Morgan, N J Dimmock.   

Abstract

The immune-mediated lethal influenza in C3H/He-mg (H-2k) mice infected with A/WSN influenza virus (H1N1) was investigated. A primary class I major histocompatibility complex-restricted, CD8+ cytotoxic T lymphocyte (CTL) response was found in the lungs with a peak activity at 5 days post-infection. Monoclonal antibody depletion in vivo showed that a lethal CD8+ cell response as well as a lethal CD4+ response was generated during infection. Mice survived infection only if both CD8+ and CD4+ cells were depleted. Mice infected with the same dose of virus, but treated with defective interfering (DI) A/WSN virus develop only a transient sub-lethal respiratory disease even though multiplication of virus in the lungs is undiminished, and we have shown here that this correlates with a reduction in the local CTL response. The mechanism by which DI virus beneficially modulates the immune response is discussed; it is proposed that there is classical, but cell type-specific DI virus interference in lymphocytes but not in the cells of the lung in which virus multiplies productively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371542     DOI: 10.1099/0022-1317-73-2-375

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

Review 1.  Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?

Authors:  Nigel J Dimmock; Andrew J Easton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

2.  Neutrophil-mediated T-Cell Suppression in Influenza: Novel Finding Raising Additional Questions.

Authors:  Rachel L Zemans
Journal:  Am J Respir Cell Mol Biol       Date:  2018-04       Impact factor: 6.914

3.  Defective interfering influenza virus confers only short-lived protection against influenza virus disease: evidence for a role for adaptive immunity in DI virus-mediated protection in vivo.

Authors:  Paul D Scott; Bo Meng; Anthony C Marriott; Andrew J Easton; Nigel J Dimmock
Journal:  Vaccine       Date:  2011-07-14       Impact factor: 3.641

4.  Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.

Authors:  Callie E Bounds; Steven A Kwilas; Ana I Kuehne; Jennifer M Brannan; Russell R Bakken; John M Dye; Jay W Hooper; Lesley C Dupuy; Barry Ellefsen; Drew Hannaman; Hua Wu; Jin-an Jiao; Eddie J Sullivan; Connie S Schmaljohn
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

Review 5.  Considerations of CD8+ T Cells for Optimized Vaccine Strategies Against Respiratory Viruses.

Authors:  Toshiro Hirai; Yasuo Yoshioka
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.